Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Net Debt / (EBITDA-CAPEX)

Aerie Pharmaceuticals Net Debt / (EBITDA-CAPEX) Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Net Debt / (EBITDA-CAPEX) from 2012 to 2020.
  • Aerie Pharmaceuticals Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a -331.39% decrease of -1m year over year
  • Aerie Pharmaceuticals Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a -346.32% decrease of -1m year over year
  • Aerie Pharmaceuticals Annual Net Debt / (EBITDA-CAPEX) for 2019 was $1m a -51.22% decrease of 0m from 2018
  • Aerie Pharmaceuticals Annual Net Debt / (EBITDA-CAPEX) for 2018 was $1m a 13.76% increase of 0m from 2017
  • Aerie Pharmaceuticals Annual Net Debt / (EBITDA-CAPEX) for 2017 was $1m a -47.74% decrease of 0m from 2016
Other Ratios Metrics:
  • Aerie Pharmaceuticals Total Debt / Capital for the quarter ending June 06, 2018 was $39m a -12.45% decrease of -5m year over year
  • Aerie Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $6m a 11.47% increase of 1m year over year
  • Aerie Pharmaceuticals Total Debt / Equity for the quarter ending June 06, 2018 was $64m a -22.13% decrease of -14m year over year
View Chart On Koyfin

Quarterly AERI Net Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m
03/2018$1m

Annual AERI Net Debt / (EBITDA-CAPEX) Data

2019$1m
2018$1m
2017$1m
2016$1m
2015$0m
2014$0m
2013$3m
2012$0m
2011$1m